Vera Bril Neuromuscular Day: Dr. Claudia Sommer

Keynote Speaker: Dr. Claudia Sommer 
University of Würzburg

Our Keynote Speaker is Dr. Claudia Sommer who is Professor of Neurology at the University Hospital of Würzburg, Germany, She leads a large group of researchers focusing predominately on pain, but also on immune-mediated neuropathies. We will also have talks form Muscular Dystrophy Canada and from neuromuscular faculty and trainees from the Division of Neurology, University of Toronto.

Topic: Update on Inflammatory Neuropathies

Featuring speakers: 

Homira Osman, Muscular Dystrophy Canada. Beyond the Diagnosis: Patient Centered Perspectives of Myasthenia Gravis Care and Community in Canada

Charles Kassardjian (SMH) and Corey Bacher (SHN). The dark side of glucocorticoids and a new hope: Guidance for managing glucocorticoid complications in neuromuscular disease

Alexandria Matic, UHN. Tractography and Neurography in Inflammatory Neuropathies

Andrea Park, Sunnybrook. Experience of ALS in Younger Adults: Early Insights and Clinical Implications

Carolina Barnett-Tapia, UHN. Patient Preferences in Myasthenia Gravis: A Discrete Choice Experiment

Hernan Gonorazky, Sick Kids Hospital. Gene Transfer Therapy in DMD, New Perspectives

Denizart Santos. Sunnybrook. Neurophysiological Biomarkers in ALS: Tracing the Origins of Neurofilament Light Chain.

Dubravka Dodig, UHN. Mystery case

Juan Idiaquez UHN, A prospective, Open-label, Efficacy and Safety Study of Subcutaneous Immunoglobulin in Patients With Myasthenia Gravis

Muhammad Khatib, UHN. Thymectomy and Risk of Other Autoimmune Disease in MG.

Generously supported by Partnership Program of the Division of Neurology, Alexion, Alnylam, Argenx, AstraZeneca, EMD Serono, Grifols, Johonson & Johnson, Mitsubishi Tanabe Pharma Canada, Novartis, Paladin Pharma, Roche and UCB.